Study points to therapeutic target for common, aggressive ovarian cancer

Small, non-coding molecules called microRNAs are known to play an important role in cancer development. Researchers now have shown their significance is greater than previously thought, a finding that could lead to new therapeutic approaches for the most common and deadly form of ovarian cancer. (Mehr in: Cancer News — ScienceDaily)